Navigation Links
New targeted drug helps smokers stub it out
Date:3/17/2011

Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.

Nicotine is absorbed rapidly through the lining of the mouth but most readily through the lungs, from where it quickly passes through the body and into the brain. Once the nicotine reaches the liver, it is metabolised by an enzyme called CYP2A6. Preliminary studies by the Canadian partner of the research project have shown that inhibitors of the nicotine-metabolising CYP2A6 enzyme can help smokers curb the need to smoke. Unfortunately, current CYP2A6 inhibitors are not viable options for anti-smoking therapy, as they involve too many adverse effects.

"We're working on developing a CYP2A6 inhibitor, a targeted drug that would only be effective in specific parts of the body. Thankfully, we have a very clear picture of the structure of CYP2A6, and we'll be able to use computer-aided modelling methods to design molecules that will bind specifically to the target without disturbing other functions in the body. We've now finished our four-year project and have discovered several molecules of an until-now-unknown structure. Along the way, we've gained new insights into how the molecules bind to the active centre of the CYP2A6 enzyme. However, it'll take a good while and money before these molecules can be developed into a targeted drug," says Hannu Raunio, the principal investigator of the research project and Professor of Pharmacology at the University of Eastern Finland.

Traditional anti-smoking therapy has long been focused on smoking cessation. At present, there are a wide variety of treatments available to help smokers quit. Nicotine, buproprion and varenicline are among the most common drugs used in the treatment of smoking a
'/>"/>

Contact: Professor Hannu Raunio
hannu.raunio@uef.fi
358-405-200-202
Academy of Finland
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ohio State study: Targeted ovarian cancer therapy not cost-effective
2. VCU Massey first to combine targeted agents to kill multiple myeloma cells
3. IU Personalized Medicine Institute to develop targeted and individualized treatments
4. Targeted particle fools brains guardian to reach tumors
5. PET scans may allow early prediction of response to targeted therapy of thyroid cancer
6. UMMS and Lundbeck to explore potential targeted therapy for Huntingtons disease
7. Study provides molecular rationale for combining targeted agents to treat breast cancer
8. Protein targeted to stop melanoma tumor growth
9. International clinical trial tests targeted drug for melanoma
10. Targeted breast ultrasound plays key role in evaluating breast abnormalities in women younger than 40
11. Targeted therapy reactivates guardian of the genome in resistant cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 All Canada Goose Parkas ... go from classic to modern. With unique detailing such as ... them is a step up in opulence. Recently, the company ... Parkas for 2014. , True enough, the new ... great discounts (up to 28% off) on all these brand ...
(Date:8/27/2014)... Today, Zane Benefits, the #1 Online Health ... administering a premium reimbursement plan. , According to ... is top of mind for employers, health insurance brokers, ... and premium reimbursement, there are important compliance considerations to ... webinar, Zane Benefits President, Rick Lindquist, will cover three ...
(Date:8/27/2014)... Locating an approximate price for an insurance ... information before rates would be viewable. The Quotes Pros ... are distributed online using its policy locator at ... adult has access to review using the national finder ... for quotation distribution built in 2013 is now programmed ...
(Date:8/27/2014)... iFitDress.com, a professional company of women’s dresses and related ... bridal gowns . To top it all off, all ... percent off) when buying the company’s new items. ... with these new items. All its online sales representatives ... can gain an enjoyable shopping experience on its website. ...
(Date:8/27/2014)... Md. (PRWEB) August 27, 2014 ... recently released guidelines for the management and treatment ... Therapy for Pulmonary Arterial Hypertension in Adults: CHEST ... free to view for clinicians, and provide the ... , The Pulmonary Hypertension Association (PHA) ...
Breaking Medicine News(10 mins):Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Life Insurance Quotes for Term Policies Now Found at Insurer Website Online 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2
... Oct. 8 Plexus Systems, Inc.,provider of ... today announced a set of enhancements for ... integrated program that will,provide enterprise-wide compliance with ... regulations mandated by the U.S. Food and ...
... LISBON, Portugal and NEW YORK, Oct. ... Hopkins University scientists the most prestigious,vision award ... combating blindness, the,Antonio Champalimaud Foundation continued its ... of its 300,000-square-foot research,facility. The Champalimaud Foundation ...
... be able to share information collected from many thousands of ... Australian National University in Canberra today. , The ANU node ... the John Curtin School of Medical Research, Garran Road, ANU ... to attend for a demonstration of the Grid and interviews. ...
... gaps exist between states, and between poor, middle- and ... News) -- For American children, the state they live ... determine how healthy they are, a new survey shows. ... are in less than optimal health, according to the ...
... service for its smartTOUCH(R),product line, JERICHO, N.Y., ... today announced that it has signed a three ... Mr.,Handyman, to provide its customers professional installation and,programming ... door openers, door locks, thermostats, mailboxes and more., ...
... Cleared for,Patients Who Have Not Benefited From Prior ... Neuronetics, Inc., a,privately-held medical device company and a ... the U.S. Food and Drug Administration,(FDA) has cleared ... the treatment of depression. NeuroStar TMS Therapy(R) is,specifically ...
Cached Medicine News:Health News:Plexus Online Enhances Functions for Medical Device Manufacturing Regulatory Compliance 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 3Health News:Medical data 'Internet' goes live, boosts research 2Health News:Family Income Impacts Children's Health 2Health News:Family Income Impacts Children's Health 3Health News:Family Income Impacts Children's Health 4Health News:Family Income Impacts Children's Health 5Health News:bioMETRX Teams Up With Mr. Handyman 2Health News:bioMETRX Teams Up With Mr. Handyman 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 2Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 4Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 5
(Date:8/27/2014)... 27, 2014 Pulse Systems, Inc. , an ... Practice Management , and Revenue Cycle Management (RCM) solutions ... performed by some RCM vendors, at UBM Medica,s Practice ... on September 19-20, 2014.  A presenter at ... September with a new session encouraging practices to "Look before ...
(Date:8/27/2014)... An experimental drug designed to help regulate the ... for anemia of inflammation, according to results from the first ... in Blood , the Journal of the ... Anemia is a condition that occurs when red blood cells ... an individual has anemia, the body does not get enough ...
(Date:8/27/2014)... STATESVILLE, N.C. , Aug. 27, 2014 ... today its Board of Directors increased its quarterly cash ... from eleven cents per outstanding share, beginning with the ... record at the close of business on September 8, ... Founded in 1906, Kewaunee Scientific Corporation is ...
Breaking Medicine Technology:Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... 2011 The Specialty Pharma Association announces its Fall Conference - ... 2011, San Diego Marriott Marquis Hotel & Marina ... Robert Greenwood, RPh President National ... PgMP, TSPM, ITBMC President TenStep, Inc. ...
... N.J. and PHILADELPHIA, Aug. 22, 2011 Oncobiologics, ... an agreement to co-develop a novel, next-generation bi-specific ... solid tumors. The jointly engineered platform is designed ... promising cancer treatments. This research program is now ...
Cached Medicine Technology:Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform 2Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform 3
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: